Benazepril hydrochloride Le Vet 5 mg tablets for dogs
Benazepril hydrochloride Le Vet 5 mg tablets for dogs
Authorised
- Benazepril hydrochloride
Product identification
Medicine name:
Benazepril hydrochloride Le Vet 5 mg tablets for dogs
Benakor F 5 mg Tablet
Benakor F 5 mg Comprimé
Benakor F 5 mg Tablette
Active substance:
- Benazepril hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Benazepril hydrochloride5.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Carton box containing 5 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 7 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 7 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 6 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 6 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 1 PVC-PE-PVDC-Alu-foil blisters of 14 tablets
- Carton box containing 1 Alu-Alu-foil blisters blisters of 14 tablets
- Carton box containing 5 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 4 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 4 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 3 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 3 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 2 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 2 Alu-Alu -foil blisters blisters of 14 tablets each
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
- Genera d.d.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0126/002
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Estonia
-
Finland
-
France
-
Ireland
-
Italy
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 8/04/2023
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: